Pharmacokinetic study of Kovaltry in thirty-five pediatric patients aged <12 years with severe hemophilia A

Huang, K; Zhen, YZ; Li, G; Wu, XY; Wu, RH; Chen, ZP

Chen, ZP (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Hematol Oncol Ctr, Beijing 100045, Peoples R China.

HAEMOPHILIA, ; ():

Abstract

Background Kovaltry (BAY81-8973) is an unmodified full-length factor VIII (FVIII) concentrate that enhances the pharmacokinetic (PK) profiles as compa......

Full Text Link